14930146 · Active · incorporated 3 years, 3 months ago · London
Biotech AI Biotech & Life Sciences Drug Discovery Series B+
Trogenix is a biotechnology company developing AAV gene therapies and Synthetic Super Enhancers for cancer treatment.
Trogenix Ltd is a private limited company registered at Companies House under number 14930146, incorporated on 12 June 2023, with a registered office in London. Its current status on the register is active. Its filed nature of business is research and experimental development on biotechnology (SIC 72110). Sonde has indexed 45 filings for this company, including 3 funding rounds. Its most recent round closed in October 2025, raising £18.2m.
| Round | Closed | Raised | Price per share |
|---|---|---|---|
| Round 3 | Oct 2025 | £18.2m | £170.00 |
| Round 2 | Mar 2025 | £9m | £100.00 |
| Round 1 | Feb 2024 | £3.5m | £100.00 |
Showing the 10 most recent of 45 filings.
See the complete cap table with every shareholder, founder tags, dilution across 11 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.